The Botswana Medicines Regulatory Authority (BoMRA) has announced a voluntary recall of 35 batches of eight medicines manufactured by Remedica Limited.
The recall was initiated by Remedica through its local distributor Pharm Vision (Pty) Ltd. The authority did not state the reason for the recall.
Members of the public holding any of the affected batches should stop using them immediately and return the products to the pharmacy or point of purchase. They should follow the supplier’s instructions regarding return or replacement, and seek advice from a healthcare professional regarding continued treatment where applicable.
Patients who have used any of the affected batches and experience suspected adverse effects should seek medical attention and report the suspected adverse drug reaction to BoMRA.
The recall is limited to the specific batches identified in the table below:
| Registration Number | Product | Generic Name | Pack Size | Batch Number | Expiry Date |
| BOT9800128 | Bralix Capsule 5mg/2.5mg | Chlordiazepoxide and Clidinium 5mg/2.5mg | 30 | 97921 109041 100250 | 11/2026 04/2028 02/2027 |
| BOT9800133 | Carbimazole tablets 5MG | Carbimazole | 100 | 119012 121187 125422 125423 | 01/08/2026 01/12/2026 01/07/2027 01/07/2027 |
| BOT1402581A/B | Clonotril tablets 2mg | Clonazepam | 30 | 103409 103410 111387 118362 127305 | June 2027 June 2027 July 2028 July 2029 November 2030 |
| BOT0100453 | Cloxacillin Capsules 250mg | Cloxacillin | 100 | 122368 127170 | March 2028 December 2028 |
| BOT0100454 | Credanil 100mg/25mg | Levodopa/Carbidopa | 100 | 104433 110135 120579 120580 126187 126935 126936 | 09/2027 06/2028 11/2029 11/2029 10/2030 11/2030 11/2030 |
| BOT1803407 | Remathen 100mg | Remathen Prolonged release | 100 | 107963 122606 111947 | March 2028 March 2030 September 2028 |
| BOT 302366 | Gabapentin (Gabenil) 100mg Hard Capsules (pack of 100). | Gabenil 100mg | 100 | 114755 126777 | 26/01/2027 10/11/2028 |
| BOT0801109 | Griseofulvin 500mg tablets (pack of 100’s). | Griseofulvin 500mg | 100 | 110026 104383 | 12/06/2028 22/09/2027 |
Healthcare professionals and the public are encouraged to report any suspected adverse drug reactions to BoMRA through the available reporting platforms.
Source: Botswana Medicines Regulatory Authority (BoMRA), “Voluntary Recall Of Specified Batches Of Medicines Manufactured By Remedica Limited”, 9 October 2026: https://www.bomra.co.bw/voluntary-recall-of-specified-batches-of-medicines-manufactured-by-remedica-limited/
